News | March 01, 2024
Briefs: Eugia Pharma Specialities and Eugia SEZ
Eugia Pharma Specialities restarts production at terminally sterilized product lines
Eugia Pharma Specialities restarts production at terminally sterilized product lines
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
The registered capital of the newly founded company is € 50 million
He is also inducted as a member of the management council and senior management personnel of the company
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
His resignation would be effective from March 18, 2024
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Subscribe To Our Newsletter & Stay Updated
